Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01177 SINO BIOPHARM
RTNominal down7.840 -0.260 (-3.210%)
Research Report

03/12/2020 10:55

{I-bank focus}MacQ trims Sino Biopharm (01177) to HK$8.39

[ET Net News Agency, 3 December 2020] Macquarie trimmed its target price for Sino
Biopharmaceutical (01177) to HK$8.39 from HK$9.52 and retained its "neutral" rating.
The research house noted that management has not provided guidance for 2020 throughout
the year and, with just one month left, the chance of a meaningful recovery is close to
nil.
Macquarie's estimates continue to be among the lowest on the street, projecting flattish
full-year revenue and earnings growth. These already imply a 14% jump in revenue and 50%
for core earnings for 4Q, which was usually the weakest quarter of the year. Thus, there
may be further downside risks. (KL)

Remark: Real time quote last updated: 12/04/2021 13:08
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.